Teleflex plans job cuts amid restructuring plan

Medical device outfit Teleflex ($TFX) is planning to cut its payroll and consolidate some operations in an effort to save cash. The Pennsylvania company isn't getting into specifics but said it expected to spend as much as $53 million on termination benefits, facility closures and depreciation charges through 2016. The effort will help save between $28 million and $35 million a year starting in 2015, Teleflex said. More

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.